Skip to main content
. 2022 Jun 14;9:898782. doi: 10.3389/fnut.2022.898782

Table 3.

Discriminant variables measured during the OGTT.

A B t test Pearson corr x Glucose A/B
Mean SEM N Mean SEM N p-Value q value rho p-value
Bile acids
TUDCA (%) 0.33 0.06 30 0.20 0.02 35 0.021 0.087 0.06 0.6505 1.67
Unconj. BA (%) 38.59 2.83 33 31.36 2.67 39 0.068 0.132 0.24 0.0414 1.23
Conj./ Unconj. BA 2.95 0.41 33 4.44 0.53 39 0.034 0.088 −0.31 0.0079 0.66
Gly-conj. BA (%) 51.85 2.26 33 60.36 2.28 39 0.011 0.068 −0.28 0.0179 0.86
Gly-conj. BA (nmol/L) 1,597.61 127.71 33 2,345.40 273.06 39 0.022 0.087 −0.26 0.0262 0.68
GCDCA (nmol/L) 853.72 79.15 33 1,164.85 106.33 39 0.026 0.087 −0.25 0.0380 0.73
Fatty acid-derived acylcarnitines
C14 (μmol/L) 0.02 0.00 33 0.02 0.00 39 0.028 0.087 0.35 0.0028 1.18
C16 (μmol/L) 0.11 0.01 33 0.10 0.00 39 0.033 0.088 0.39 0.0007 1.14
C18 (μmol/L) 0.03 0.00 33 0.02 0.00 39 0.039 0.096 0.31 0.0083 1.16
C3 (μmol/L) 0.34 0.02 33 0.26 0.01 39 0.004 0.055 0.47 3.13E-05 1.28
C4 (μmol/L) 0.07 0.01 33 0.05 0.00 39 0.018 0.087 0.37 0.0014 1.37
C6 (μmol/L) 0.04 0.00 33 0.03 0.00 39 0.018 0.087 0.39 0.0008 1.34
Amino acids and amino acid-related metabolites
Isovaleryl-carnitine (μmol/L) 0.08 0.01 33 0.06 0.00 39 0.011 0.068 0.56 4.00E-07 1.25
Spermidine (μmol/L) 0.18 0.03 33 0.12 0.01 39 0.041 0.097 0.41 0.0004 1.53
Spermine (μmol/L) 0.25 0.06 33 0.13 0.01 39 0.031 0.087 0.33 0.0052 1.90
Urea (mmol/L) 5.94 0.21 33 5.34 0.20 39 0.047 0.100 0.13 0.2626 1.11
Free carnitine (μmol/L) 39.65 1.49 33 35.94 1.30 39 0.064 0.129 0.26 0.0290 1.10
Glu (μmol/L) 51.52 4.43 33 31.41 2.39 39 0.0001 0.0017 0.64 1.39E-09 1.64
Ile (μmol/L) 59.61 2.20 33 53.16 1.90 39 0.029 0.087 0.56 3.31E-07 1.12
Leu (μmol/L) 114.85 4.51 33 101.89 3.12 39 0.018 0.087 0.52 2.21E-06 1.13
Phe (μmol/L) 53.84 1.38 33 49.93 1.09 39 0.028 0.087 0.30 0.0114 1.08
Trp (μmol/L) 54.19 1.26 33 49.66 1.20 39 0.011 0.068 0.33 0.0051 1.09
Val (μmol/L) 202.08 6.18 33 186.47 4.78 39 0.046 0.100 0.53 1.30E-06 1.08
Gln (μmol/L) 575.08 11.52 33 622.93 12.04 39 0.006 0.056 −0.29 0.0140 0.92
Gly (μmol/L) 206.06 9.64 33 247.27 12.05 39 0.011 0.068 −0.31 0.0077 0.83
Ser (μmol/L) 92.49 2.74 33 101.72 3.18 39 0.035 0.088 −0.22 0.0602 0.91
Glucose metabolism
Glucose (mmol/L) 7.62 0.21 33 5.64 0.09 39 <0.000001 <0.000001 1 1.35
Insulin (mIU/L) 80.99 5.94 33 49.65 4.13 39 0.00003 0.00130 0.56 2.87E-07 1.63
Mannose (AU) 0.82 0.05 33 0.69 0.05 39 0.056 0.116 0.47 2.95E-05 1.18
Meso-Erythritol (AU) 1.42 0.10 33 1.18 0.05 39 0.030 0.087 0.24 0.0413 1.20
Threitol (AU) 1.41 0.10 33 1.17 0.04 39 0.023 0.087 0.27 0.0225 1.21
Pyruvate (AU) 1.22 0.10 33 0.98 0.07 39 0.042 0.097 0.37 0.0013 1.25
Lipids
Palmitic acid (AU) 2.35 0.12 33 2.01 0.09 39 0.029 0.087 0.31 0.0080 1.17
Stearic acid (AU) 2.13 0.09 33 1.81 0.07 39 0.005 0.055 0.32 0.0060 1.18
Cholesterol (AU) 2.57 0.19 33 2.09 0.14 37 0.045 0.100 0.16 0.1951 1.23
Triglycerides (mmol/L) 1.52 0.08 33 1.09 0.06 39 0.0001 0.0017 0.52 2.37E-06 1.39
Leucocytes
Monocytes (giga/L) 0.50 0.03 33 0.39 0.02 39 0.005 0.055 0.25 0.0340 1.27
Neutrophils (giga/L) 3.88 0.46 33 2.83 0.14 39 0.023 0.087 0.23 0.0518 1.37
White blood cells (giga/L) 6.31 0.49 33 4.98 0.18 39 0.008 0.068 0.27 0.0206 1.27

The variables measured in samples collected during the OGTT that received a VIP value > 1 in the PLS-DA model at a minimum of two time points are presented with the average concentration during the test. The differences between the 2 clusters were tested with a T-test and their correlation (Pearson) with the average glucose concentration during the OGTT is presented. The right (last) column presents the ratio of each variable between cluster A and B individuals. Highlighted rows indicate variables predominantly associated with cluster B. Variables not considered different between the two clusters after the T-test were not included in the table.